By Associate Professor Handan Cetin Wand

Journal articles

Raboud JM; Diong C; Carr AD; Grinspoon SK; Mulligan K; Sutinen J; Rozenbaum W; Cavalcanti RB; Wand HC; Costagiola D; Walmsley S, 2010, 'A Meta-Analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy', HIV Clinical Trials, 11, pp. 39 - 50

Iversen J; Wand H; Gonnermann A; Maher L, 2010, 'Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008', International Journal of Drug Policy, 21, pp. 471 - 476, http://dx.doi.org/10.1016/j.drugpo.2010.04.004

Falster KA; Wand HC; Donovan BJ; Anderson JS; Nolan D; Watson K; Watson J; Law MG, 2010, 'Hospitalizations in a cohort of HIV patients in Australia, 1999-2007', AIDS, 24, pp. 1329 - 1339

Wand HC; Yan P; Wilson DP; McDonald AM; Middleton MG; Kaldor JM; Law MG, 2010, 'Increasing HIV transmission through male homosexual and heterosexual contact in Australia: results from an extended back-projection approach', HIV Medicine, 11, pp. 395 - 403

Calmy A; Bloch M; Wand HC; Delhumeau C; Finlayson R; Rafferty M; Norris R; Hirschel B; Cooper DA; Carr AD, 2010, 'No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial', HIV Medicine, 11, pp. 497 - 501

Wand H; Ramjee G, 2010, 'Targeting the hotspots: Investigating spatial and demographic variations in HIV infection in small communities in South Africa', Journal of the International AIDS Society, 13, pp. 1 - 9, http://www.jiasociety.org/content/13/1/41

McNulty A; Egan C; Wand H; Donovan B, 2010, 'The behaviour and sexual health of young international travellers (backpackers) in Australia', Sexually Transmitted Infections, 86, pp. 247 - 250, http://dx.doi.org/10.1136/sti.2009.038737

Harcourt CL; O Connor J; Egger SJ; Fairley CK; Wand HC; Chen M; Marshall L; Kaldor JM; Donovan BJ, 2010, 'The decriminalisation of prostitution is associated with better coverage of health promotion programs for sex workers', Australian and New Zealand Journal of Public Health, 34, pp. 482 - 486

Chen M; Millwood I; Wand HC; Poynten IM; Law MG; Kaldor JM; Wesselingh S; Price C; Clark L; Pauli J; Fairley CK, 2009, 'A randomized controlled trial of the safety of candidate microbicide SPL7013 gel when applied to the penis', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 50, pp. 375 - 380

Nakhaee FH; Black DA; Wand HC; McDonald AM; Law MG, 2009, 'Changes in mortality following HIV and AIDS and estimation of the number of people living with diagnosed HIV/AIDS in Australia, 1981-2003', Sexual Health, 6, pp. 129 - 134, http://dx.doi.org/10.1071/SH08007

Wand HC; Wilson DP; Yan P; Gonnermann A; McDonald AM; Kaldor JM; Law MG; Han A, 2009, 'Characterizing trends in HIV infection among men who have sex with men in Australia by birth-cohorts: results from a modified back-projection method', Journal of the International AIDS Society, 12, pp. 19 - 19, http://dx.doi.org/10.1186/1758-2652-12-19

Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2009, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism', Current HIV Research, 7, pp. 454 - 461

Read TRH; Carey DL; Mallon PW; Mijch A; Goodall R; Hudson F; Wand HC; Emery S, 2009, 'Efavirenz plasma concentrations did not predict cessation of therapy due to neuropsychiatric symptoms in a large randomized trial', AIDS, 23, pp. 2222 - 2223, http://dx.doi.org/10.1097/QAD.0b013e32832e95f8

Klug G; Wand HC; Boyd A; Law MG; Whyte S; Kaldor JM; Masters C; Collins S, 2009, 'Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster', Brain, 132, pp. 493 - 501, http://dx.doi.org/10.1093/brain/awn303

Wand H; Spiegelman D; Law M; Jalaludin B; Kaldor J; Maher L, 2009, 'Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning', Addiction, 104, pp. 2049 - 2056, http://dx.doi.org/10.1111/j.1360-0443.2009.02704.x

McDonald AM; Zurynski Y; Wand HC; Giles M; Elliot E; Ziegler JB; Kaldor JM, 2009, 'Perinatal exposure to HIV among children born in Australia, 1982-2006', Medical Journal of Australia, 190, pp. 416 - 420

Donovan B; O'Connor JL; Harcourt C; Egger S; Wand H; Chen MY; Tabrizi S; Marshall L; Kaldor JM; Fairley CK, 2008, 'THE LAW AND SEXWORKER HEALTH (LASH) PROJECT', SEXUAL HEALTH, 5, pp. 382 - 383, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000260999000023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

O'Connor JL; Harcourt C; Wand H; Egger S; Fairley CK; Kaldor JM; Marshall L; Bates JL; Donovan B, 2008, 'THE SEX INDUSTRY IN PERTH BEFORE DECRIMINALISATION', SEXUAL HEALTH, 5, pp. 384 - 384, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000260999000027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Calmy A; Carey DL; Mallon PW; Wand HC; Law MG; Cooper DA; Carr AD, 2008, 'Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy', HIV Medicine, 9, pp. 101 - 110, http://dx.doi.org/10.1111/j.1468-1293.2007.00527.x

Herzmann C; Cuthbertson Z; Fosdick L; Fisher M; Nelson M; Perry NB; Law MG; Wand HC; Janossy G; Johnson MA; Youle M, 2008, 'Long-term clinical and surrogate marker effects of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients', Journal of Antimicrobial Chemotherapy, 62, pp. 583 - 586, http://dx.doi.org/10.1093/jac/dkn238

Topp L; Iversen J; Wand H; Day C; Kaldor J; Maher L, 2008, 'Representativeness of injecting drug users who participate in HIV surveillance: Results from Australia`s needle and syringe program survey', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 47, pp. 632 - 638

Donovan BJ; O Connor J; Harcourt CL; Egger SJ; Wand HC; Chen M; Tabrizi S; Marshall L; Kaldor JM; Fairley CK, 2008, 'THE LAW AND SEXWORKER HEALTH (LASH) PROJECT', Sexual Health, 5, pp. 4 - 5

O Connor J; Harcourt CL; Wand HC; Egger SJ; Fairley CK; Kaldor JM; Marshall L; Bates J; Donovan BJ, 2008, 'THE SEX INDUSTRY IN PERTH BEFORE DECRIMINALISATION', Sexual Health, 5, pp. 8 - 9

Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A, 2007, 'Erratum: Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia (Diabetes Care (2007) 30, (113-119))', Diabetes Care, 30, pp. 455, http://dx.doi.org/10.2337/dc07-er02

Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A, 2007, 'Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia (vol 30, pg 113, 2007)', DIABETES CARE, 30, pp. 455 - 455, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000244024100062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor J, 2007, 'Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia', Drug and Alcohol Dependence, 89, pp. 244 - 250, http://dx.doi.org/10.1016/j.drugalcdep.2007.01.001

Wand HC; Calmy A; Carey DL; Samaras K; Carr AD; Law MG; Cooper DA; Emery S, 2007, 'Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV-infected adults', AIDS, 21, pp. 2445 - 2453

Spiegelman D; Hertzmark E; Wand HC, 2007, 'Point and interval estimates of partial population attributable risks in cohort studies: examples and software', Cancer Causes and Control, 18, pp. 571 - 579, http://dx.doi.org/10.1007/s10552-006-0090-y

Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2007, 'Prevalence of Metabolic Syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria', Diabetes Care, 30, pp. 113 - 119, http://dx.doi.org/10.2337/dc06-1075

Spillane H; Mcnulty A; Wand HC; Tribe KL; Donovan BJ, 2007, 'Who declines to give a name at a sexual health service?', Sexually Transmitted Infections, 83, pp. 160 - 162, http://dx.doi.org/10.1136/sti.2006.021709

Group* ER; Group: W; Pett SL; Wand H; Law MG; Arduino R; Lopez JC; Knysz B; Pereira LC; Pollack S; Reiss P; Tambussi G, 2006, 'Evaluation of Subcutaneous Proleukin (Interleukin-2) in a Randomized International Trial (ESPRIT): Geographical and Gender Differences in the Baseline Characteristics of Participants', HIV Research & Clinical Practice, 7, pp. 70 - 85, http://dx.doi.org/10.1310/hct.2006.7.2.005

Youle M; Emery S; Fisher M; Nelson M; Fosdick L; Janossy G; Loveday C; Sullivan AM; Herzmann C; Wand HC; Davey Jr R; Johnson MA; Tavel JA; Lane HC; Sullaphen J, 2006, 'A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: The UK-Vanguard study.', PLoS Clinical Trials, 1, pp. e3 - e3, http://dx.doi.org/10.1371/journal.pctr.0010003

Kelleher AD; Puls R; Bebbington M; Boyle D; Kent S; Kippax SC; Purcell D; Thomson S; Wand HC; Cooper DA; Emery S; Ffrench RA, 2006, 'A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1', AIDS, 20, pp. 294 - 297

Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2006, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition and metabolic parameters', Antiviral Therapy, 11, pp. L23 - L24

Calmy A; Carey DL; Mallon PW; Wand HC; Cooper DA; Law MG; Carr AD, 2006, 'Early changes in adiponectin and leptin levels predict changes in limb fat mass over 2 years following initiation of antiretroviral therapy', Antiviral Therapy, 11, pp. L12 - L12

Pett SL; Wand HC; Law MG; Arduino R; Lopez JC; Knysz B; Pereira L; Pollack S; Reiss P; Tambussi G, 2006, 'Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants', HIV Clinical Trials, 7, pp. 70 - 85

Spillane H; Mcnulty A; Wand HC; Tribe KL; Donovan BJ, 2006, 'Who declines to give a name in a sexual health service?', Sexually Transmitted Infections, 83, pp. 160 - 162, http://dx.doi.org/10.1136/sti.2006.021709

Mallon PW; Wand HC; Law MG; Miller J; Cooper DA; Carr AD, 2005, 'Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia.', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 38, pp. 156 - 162, http://journals.lww.com/jaids/Fulltext/2005/02010/Buffalo_Hump_Seen_in_HIV_Associated_Lipodystrophy.6.aspx

Carey DL; Wand HC; Martin A; Rothwell S; Emery S; Cooper DA; Carr AD, 2005, 'Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trial', AIDS, 19, pp. 1325 - 1327

Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2005, 'Increase in limb fat after nucleoside analogue cessation is not associated with decreased visceral fat and has different risk factors', Antiviral Therapy, 10, pp. L5 - L5

Kovacic JC; Martin A; Carey DL; Wand HC; Mallon PW; Feneley MP; Emery S; Cooper DA; Carr AD, 2005, 'Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy', Antiviral Therapy, 10, pp. 135 - 143

Cavalcanti RB; Raboud J; Kain KC; Walmsley S; Carr A; Wand H, 2004, 'Rosiglitazone for HIV-1 lipoatrophy [3] (multiple letters)', Lancet, 363, pp. 1828 - 1829, http://dx.doi.org/10.1016/S0140-6736(04)16318-6

Carr AD; Workman C; Carey DL; Rogers GJ; Martin A; Baker DA; Wand HC; Law MG; Samaras K; Emery S; Cooper DA, 2004, 'No effect of rosiglitazone for treatment of HIV-1 lipoatrophy:randomised, double-blind, placebo-controlled trial', Lancet, 363, pp. 429 - 438, http://dx.doi.org/10.1016/S0140-6736(04)15489-5

Joshipura KJ; Wand HC; Merchant AT; Rimm EB, 2004, 'Periodontal disease and biomarkers related to cardiovascular disease', Journal of Dental Research, 83, pp. 151 - 155, http://dx.doi.org/10.1177/154405910408300213

Martin A; Smith DE; Carr AD; Hoy JF; Chuah J; Mallal SA; Law MG; Clements MS; Cooper DA, 2004, 'Progression of lipodystrophy (LD) with continued thymidine analogue usage: Long-term follow-up from a randomized clinical trial (the PIILR study)', HIV Clinical Trials, 5, pp. 192 - 200, http://thomasland.metapress.com/content/0gu76x27mmhe5ale/

Carey DL; Workman C; Rogers GJ; Baker DA; Martin A; Wand HC; Emery S; Cooper DA; Carr AD, 2004, 'Rosiglitazone for HIV lipoatrophy: 84 weeks follow-up', Antiviral Therapy, 9, pp. L46 - L46

Carr AD; Wand HC, 2004, 'Rosiglitazone for HIV-1 Lipoatrophy', The Lancet, 363, pp. 1829 - 1829, http://dx.doi.org/10.1016/S0140-6736(04)16319-8

Carr AD; Wand HC, 2004, 'Rosiglitazone for HIV-1 lipoatrophy - Reply', Lancet, 363, pp. 1829 - 1829

Mallon PW; Wand HC; Law MG; Miller JM; Cooper DA; Carr AD, 2003, 'Strong association between buffalo hump and high serum insulin concentrations in HIV-infected individuals', Antiviral Therapy, 8, pp. L61 - L61

Rich-Edwards JW; Spiegelman D; Garland M; Hertzmark E; Hunter DJ; Colditz GA; Willett WC; Wand H; Manson JAE, 2002, 'Physical activity, body mass index, and ovulatory disorder infertility', Epidemiology, 13, pp. 184 - 190, http://dx.doi.org/10.1097/00001648-200203000-00013

Back to profile page